Eosinophilic asthma is a type of asthma that is characterized by high levels of eosinophils in the airways. Eosinophils are a type of white blood cell that are involved in the body’s immune response to allergens and other triggers. When eosinophils are activated, they release inflammatory chemicals that can cause damage to the airways, leading to asthma symptoms.

Symptoms of eosinophilic asthma include wheezing, coughing, shortness of breath, and chest tightness. These symptoms may be more severe than those of other types of asthma and may not respond as well to traditional asthma treatments like inhaled corticosteroids.

 You may be eligible to participate if you: 

• Be 12 years and up
• Diagnosed with eosinophilic asthma
• Must be taking at least one medium to high dose maintenance inhaler daily, with another asthma medication

There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study-related vaccine (or placebo) & medical exams at no cost, and a stipend for time and travel. No health insurance is required to participate. 

For more information call:

(904) 379-7334 or (904) 732-6669